CVS Health Corp (NYSE:CVS) Shares Sold by Riverhead Capital Management LLC

Riverhead Capital Management LLC decreased its holdings in CVS Health Corp (NYSE:CVS) by 52.1% in the 2nd quarter, HoldingsChannel reports. The firm owned 15,088 shares of the pharmacy operator’s stock after selling 16,439 shares during the quarter. Riverhead Capital Management LLC’s holdings in CVS Health were worth $822,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Nordea Investment Management AB boosted its position in shares of CVS Health by 2.8% during the 1st quarter. Nordea Investment Management AB now owns 12,426,745 shares of the pharmacy operator’s stock worth $670,172,000 after acquiring an additional 340,315 shares in the last quarter. M&R Capital Management Inc. lifted its position in shares of CVS Health by 3.0% during the 1st quarter. M&R Capital Management Inc. now owns 130,126 shares of the pharmacy operator’s stock worth $6,965,000 after buying an additional 3,794 shares during the last quarter. Mathes Company Inc. boosted its holdings in shares of CVS Health by 61.0% in the 1st quarter. Mathes Company Inc. now owns 14,250 shares of the pharmacy operator’s stock valued at $769,000 after buying an additional 5,400 shares in the last quarter. World Asset Management Inc boosted its holdings in shares of CVS Health by 23.7% in the 1st quarter. World Asset Management Inc now owns 110,866 shares of the pharmacy operator’s stock valued at $5,979,000 after buying an additional 21,261 shares in the last quarter. Finally, Berkeley Capital Partners LLC grew its position in shares of CVS Health by 8.1% in the 2nd quarter. Berkeley Capital Partners LLC now owns 18,337 shares of the pharmacy operator’s stock valued at $999,000 after buying an additional 1,380 shares during the last quarter. 76.06% of the stock is owned by institutional investors and hedge funds.

Shares of NYSE CVS traded down $0.04 during trading on Wednesday, hitting $63.57. 3,530,660 shares of the company were exchanged, compared to its average volume of 7,591,594. The company has a market cap of $82.82 billion, a price-to-earnings ratio of 8.98, a PEG ratio of 1.39 and a beta of 0.85. CVS Health Corp has a 1 year low of $51.72 and a 1 year high of $82.15. The firm’s fifty day moving average price is $59.11 and its 200 day moving average price is $55.84. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64.



CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The business had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same quarter last year, the firm posted $1.69 EPS. The business’s revenue was up 35.2% compared to the same quarter last year. On average, research analysts forecast that CVS Health Corp will post 6.96 earnings per share for the current year.

A number of analysts have weighed in on CVS shares. ValuEngine cut CVS Health from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 2nd. Standpoint Research raised CVS Health from a “hold” rating to a “buy” rating in a report on Wednesday, June 5th. Mizuho set a $71.00 price target on CVS Health and gave the stock a “buy” rating in a research note on Wednesday, June 5th. Cowen reaffirmed an “outperform” rating and set a $76.00 price target (up from $69.00) on shares of CVS Health in a report on Tuesday, August 27th. Finally, TheStreet upgraded shares of CVS Health from a “c+” rating to a “b-” rating in a research report on Monday. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $75.18.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Recommended Story: Hedge Funds – Risk or Reward?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.